Citation

Talbot J, Phillips JL, Blier P. J. Psychiatry Neurosci. 2019; 44(6): 384-385.

Copyright

(Copyright © 2019, Canadian Medical Association)

DOI

10.1503/jpn.190073

PMID

31573153

PMCID

PMC6821514

Abstract

A growing body of literature has shown the effectiveness of ketamine for treating chronic depression. How long the beneficial effects of repeated ketamine last once infusions are stopped, however, remains largely unknown. Understanding the challenges that ensue after ketamine cessation can help clinicians optimally guide patients who opt for ketamine treatment and minimize the associated risks. In this commentary, we discuss some unexpected data gathered from participants of a pilot study on the effects of adjunctive ketamine infusion for resistant depression.

Language: en

Keywords

Humans; Adult; Female; Male; Middle Aged; Suicidal Ideation; Suicide, Attempted; Health Services Accessibility; Ketamine; Chronic Disease; Depressive Disorder, Treatment-Resistant; Excitatory Amino Acid Antagonists; Duration of Therapy